CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Accounting Officer acquired 18,290 shares (grant or award)
- 4 Grant or award Director acquired 1,389 shares (grant or award)
- 4 Grant or award Director acquired 1,358 shares (grant or award)
- 4 Grant or award Director acquired 1,697 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 6,560 shares (to pay taxes)
- 4 Grant or award President & CEO acquired 103,400 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 36,700 shares (grant or award)
Page 5 of 15 · 296 filings